𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quantitative measurements of humoral immune response in mice to a FANFT induced bladder tumor

✍ Scribed by Studer, U.E. ;deKernion, J.B. ;Lovrekovich, H. ;Lovrekovich, L.


Publisher
Springer
Year
1985
Tongue
English
Weight
714 KB
Volume
13
Category
Article
ISSN
0300-5623

No coin nor oath required. For personal study only.

✦ Synopsis


Using unfixed mouse bladder tumor cells (MBT) as target cells and a modified avidin-biotin-complex (ABC) method made it possible to detect a humoral immune response in C3H mice with growing MBT tumors. The rise of the serum levels is significant (p less than 0.005) when compared to control animals and correlates with the tumor size. Mice with recurrences after surgical removal of the primary tumor had significantly (p less than 0.05) higher serum values than animals without recurrence. Purulent or granulomatous inflammatory changes, muscle necrosis, growth of a lymphoma or an ovarian carcinoma did not significantly change the results (p less than 0.05). Injection of myeloma cells from a different strain of mice caused a minimal, but significant increase in the values when compared to controls (p less than 0.0001). However, the slope of the curve differed significantly (p less than 0.05) from that in mice with MBT tumors. Irradiated MBT cells or Corynebacterium parvum used as immunomodulators significantly increased the serum values (p less than 0.001). In the presence of a growing MBT tumor, however, the immunomodulation did not substantially falsify the results. The serum values were related to the corresponding tumor sizes.


📜 SIMILAR VOLUMES


Transplantation immunity to individually
✍ D. V. Wahl; W. H. Chapman; I. Hellström; K. E. Hellström 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 French ⚖ 659 KB

## Abstract We have previously shown that lymphocyte‐mediated immunity to common bladder tumor antigens can be demonstrated in vitro. In this study we used two carcinomas and two sarcomas of the urinary bladder of BALB/c mice to immunize syngeneic animals against tumor‐specific transplantation anti

Cellular basis for the immune response t
✍ R. Kearney; A. Basten; D. S. Nelson 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 French ⚖ 914 KB

## Abstract Immune resistance to methylcholanthrene‐induced tumors has two phases, an early specific and a late non‐specific phase. Both phases were found to be T‐cell‐dependent in vivo. Thus, adult thymectomized, irradiated, bone‐marrow‐protected mice bearing H‐1 tumor isografts showed impaired re

The immune response to primary moloney s
✍ E. W. Lamon; B. Andersson; H. Wigzell; E. M. Fenyö; E. Klein 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 French ⚖ 974 KB

## Abstract Adult BALB/c mice injected with Moloney sarcoma virus (MSV) developed local tumors at the site of inoculation which spontaneously regressed within 20–25 days after injection. Lymphocytes and sera from long‐term regressor animals were examined for their specific activities __in vitro__ a

Immune responses to weakly immunogenic v
✍ Naomi Galili; B. Devens; D. Naor; Susanne Becker; Eva Klein 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB

## Abstract This report describes model systems which show low primary __in vitro__ syngeneic cytotoxic responses to a Moloney‐induced YAC tumor (syngeneic in A mice) and a Rauscher‐induced RBL5 tumor (syngeneic in C57BL/6 mice) and examines different approaches to overcome these defects. Two majo

Suppression of immune response to sheep
✍ Mary A. Pikovski; Y. Ziffroni-Gallon; I. P. Witz 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB 👁 1 views

## Abstract The frequency of rosette‐forming cells (RFC) in spleens of mice immunized with sheep red blood cells (SRBC) was significantly reduced by pretreatment with preparations obtained from tumor extracts. This effect was not produced by preparations obtained by similar methods from normal tiss